{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:16:47Z","timestamp":1788225407082,"version":"build-2803163510"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T00:00:00Z","timestamp":1781913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","award":["IR.SBMU.ENDOCRINE.REC.1404.119"],"award-info":[{"award-number":["IR.SBMU.ENDOCRINE.REC.1404.119"]}],"id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004887","name":"Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["1404-11-109-94429"],"award-info":[{"award-number":["1404-11-109-94429"]}],"id":[{"id":"10.13039\/501100004887","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16376-6","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:27:02Z","timestamp":1781944022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thiostrepton potentiates chemotherapy-induced cell death in cisplatin-resistant SKOV3 cells"],"prefix":"10.1186","volume":"26","author":[{"given":"Farzaneh","family":"Motafeghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan Ghassemi","family":"Barghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jafar Gholami","family":"Gharab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh Ramezani","family":"Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorour","family":"Ashari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0673-4262","authenticated-orcid":false,"given":"Nasrin Ghassemi","family":"Barghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,20]]},"reference":[{"issue":"1","key":"16376_CR1","first-page":"17","volume":"2","author":"S Shabir","year":"2020","unstructured":"Shabir S, Gill PK. Global scenario on ovarian cancer\u2013Its dynamics, relative survival, treatment, and epidemiology. Adesh Univ J Med Sci Res. 2020;2(1):17\u201325.","journal-title":"Adesh Univ J Med Sci Res"},{"issue":"3","key":"16376_CR2","doi-asserted-by":"publisher","first-page":"544","DOI":"10.3390\/medicina59030544","volume":"59","author":"A Havasi","year":"2023","unstructured":"Havasi A, Cainap SS, Havasi AT, Cainap C. Ovarian cancer\u2014insights into platinum resistance and overcoming it. Medicina. 2023;59(3):544.","journal-title":"Medicina"},{"key":"16376_CR3","doi-asserted-by":"publisher","first-page":"691795","DOI":"10.3389\/fmolb.2021.691795","volume":"8","author":"L Wang","year":"2021","unstructured":"Wang L, Zhao X, Fu J, Xu W, Yuan J. The role of tumour metabolism in cisplatin resistance. Front Mol Biosci. 2021;8:691795.","journal-title":"Front Mol Biosci"},{"issue":"4","key":"16376_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/or.2022.8293","volume":"47","author":"L Yang","year":"2022","unstructured":"Yang L, Xie H-J, Li Y-Y, Wang X, Liu X-X, Mai J. Molecular mechanisms of platinum\u2013based chemotherapy resistance in ovarian cancer. Oncol Rep. 2022;47(4):1\u201311.","journal-title":"Oncol Rep"},{"issue":"1","key":"16376_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12032-023-02237-w","volume":"41","author":"R Fu","year":"2023","unstructured":"Fu R, Zhao B, Chen M, Fu X, Zhang Q, Cui Y, et al. Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy. Med Oncol. 2023;41(1):9.","journal-title":"Med Oncol"},{"issue":"22","key":"16376_CR6","doi-asserted-by":"publisher","first-page":"12402","DOI":"10.3390\/ijms252212402","volume":"25","author":"M Roszkowska","year":"2024","unstructured":"Roszkowska M. Multilevel mechanisms of cancer drug resistance. Int J Mol Sci. 2024;25(22):12402.","journal-title":"Int J Mol Sci"},{"key":"16376_CR7","unstructured":"Height T. Ovarian, Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ\u00ae) Health Professional Version. 2024."},{"issue":"11","key":"16376_CR8","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1007\/s12094-024-03531-3","volume":"26","author":"JA Perez-Fidalgo","year":"2024","unstructured":"Perez-Fidalgo JA, G\u00e1lvez-Montosa F, Guerra EM, Madariaga A, Manzano A, Martin-Lorente C, et al. SEOM\u2013GEICO clinical guideline on epithelial ovarian cancer (2023). Clin Transl Oncol. 2024;26(11):2758\u201370.","journal-title":"Clin Transl Oncol"},{"issue":"19","key":"16376_CR9","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1158\/1078-0432.CCR-23-0991","volume":"29","author":"A Dilawari","year":"2023","unstructured":"Dilawari A, Shah M, Ison G, Gittleman H, Fiero MH, Shah A, et al. FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FR\u03b1-Positive, Platinum-Resistant Ovarian Cancer. Clin Cancer Res. 2023;29(19):3835\u201340.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"16376_CR10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41419-022-04510-8","volume":"13","author":"W Tian","year":"2022","unstructured":"Tian W, Lei N, Zhou J, Chen M, Guo R, Qin B, et al. Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion. Cell Death Dis. 2022;13(1):64.","journal-title":"Cell Death Dis"},{"issue":"8","key":"16376_CR11","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.3390\/molecules26082382","volume":"26","author":"S Mirzaei","year":"2021","unstructured":"Mirzaei S, Hushmandi K, Zabolian A, Saleki H, Torabi SMR, Ranjbar A, et al. Elucidating role of reactive oxygen species (ROS) in cisplatin chemotherapy: a focus on molecular pathways and possible therapeutic strategies. Molecules. 2021;26(8):2382.","journal-title":"Molecules"},{"issue":"1","key":"16376_CR12","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41368-025-00380-w","volume":"17","author":"J Luo","year":"2025","unstructured":"Luo J, Sun T, Liu Z, Liu Y, Liu J, Wang S, et al. Persistent accumulation of therapy-induced senescent cells: an obstacle to long-term cancer treatment efficacy. Int J Oral Sci. 2025;17(1):59.","journal-title":"Int J Oral Sci"},{"issue":"2","key":"16376_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1590\/s0004-2803.202000000-25","volume":"57","author":"M Shokrzadeh","year":"2020","unstructured":"Shokrzadeh M, Goleij P, Behravan E, Ghassemi-Barghi N, Salehabadi Y, Rezaei A. Association between diabetics and intestinal cancer with the risk of mutation in CD38 gene in Iranian population. Arq Gastroenterol. 2020;57(2):137\u201343.","journal-title":"Arq Gastroenterol"},{"issue":"1","key":"16376_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-024-01563-4","volume":"17","author":"P Song","year":"2024","unstructured":"Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y, et al. Wnt\/\u03b2-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol. 2024;17(1):46.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"16376_CR15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3892\/mmr.2020.11744","volume":"23","author":"G-X Zhu","year":"2021","unstructured":"Zhu G-X, Gao D, Shao Z-Z, Chen L, Ding W-J, Yu Q-F. Wnt\/\u03b2-catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer. Mol Med Rep. 2021;23(2):105.","journal-title":"Mol Med Rep"},{"issue":"2","key":"16376_CR16","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/ijms26020799","volume":"26","author":"AA Hasan","year":"2025","unstructured":"Hasan AA, Kalinina E, Zhdanov D, Volodina Y, Tatarskiy V. Re-sensitization of resistant ovarian cancer SKOV3\/CDDP cells to cisplatin by curcumin pre-treatment. Int J Mol Sci. 2025;26(2):799.","journal-title":"Int J Mol Sci"},{"issue":"20","key":"16376_CR17","doi-asserted-by":"publisher","first-page":"7500","DOI":"10.3390\/ijms21207500","volume":"21","author":"SI Althurwi","year":"2020","unstructured":"Althurwi SI, Yu JQ, Beale P, Huq F. Sequenced combinations of cisplatin and selected phytochemicals towards overcoming drug resistance in ovarian tumour models. Int J Mol Sci. 2020;21(20):7500.","journal-title":"Int J Mol Sci"},{"key":"16376_CR18","doi-asserted-by":"publisher","first-page":"1687805","DOI":"10.3389\/fphar.2025.1687805","volume":"16","author":"B Muttiah","year":"2026","unstructured":"Muttiah B, Abdullah NAH. Natural compounds in ovarian cancer: mechanistic insights and therapeutic potential. Front Pharmacol. 2026;16:1687805.","journal-title":"Front Pharmacol"},{"key":"16376_CR19","doi-asserted-by":"publisher","first-page":"110042","DOI":"10.1016\/j.inoche.2022.110042","volume":"146","author":"M Shirzadi-Ahodashti","year":"2022","unstructured":"Shirzadi-Ahodashti M, Mizwari ZM, Jafarkhani B, Abbastabar M, Motafeghi F, Lalerdi FS, et al. Biogenic synthesis of spherical-shaped noble metal nanoparticles using Vicia faba extract (X@ VF, X\u2009=\u2009Au, Ag) for photocatalytic degradation of organic hazardous dye and their in vitro antifungal, antibacterial and anticancer activities. Inorg Chem Commun. 2022;146:110042.","journal-title":"Inorg Chem Commun"},{"key":"16376_CR20","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.freeradbiomed.2022.09.018","volume":"193","author":"S-X Liu","year":"2022","unstructured":"Liu S-X, Zhou Y, Zhao L, Zhou L-S, Sun J, Liu G-J, et al. Thiostrepton confers protection against reactive oxygen species-related apoptosis by restraining FOXM1-triggerred development of gastric cancer. Free Radic Biol Med. 2022;193:385\u2013404.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"16376_CR21","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3390\/cancers16040756","volume":"16","author":"N Merjaneh","year":"2024","unstructured":"Merjaneh N, Hajjar M, Lan Y-W, Kalinichenko VV, Kalin TV. The promise of combination therapies with FOXM1 inhibitors for cancer treatment. Cancers. 2024;16(4):756.","journal-title":"Cancers"},{"key":"16376_CR22","doi-asserted-by":"crossref","unstructured":"Zhao X, Ma Y, Luo J, Xu K, Tian P, Lu C, et al. Blocking the WNT\/\u03b2-catenin pathway in cancer treatment: pharmacological targets and drug therapeutic potential. Heliyon. 2024;10(16):e35989.","DOI":"10.1016\/j.heliyon.2024.e35989"},{"key":"16376_CR23","doi-asserted-by":"publisher","first-page":"e931970","DOI":"10.12659\/MSM.931970","volume":"27","author":"C Yu","year":"2021","unstructured":"Yu C, Chen H, Zhao Y, Zhang Y. Forkhead Box protein M1 promotes nasopharyngeal Carcinoma Cell Tumorigenesis possibly via the Wnt\/\u03b2-Catenin signaling pathway. Med Sci Monitor: Int Med J Experimental Clin Res. 2021;27:e931970\u20131.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"issue":"4","key":"16376_CR24","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1159\/000447851","volume":"39","author":"C Xie","year":"2016","unstructured":"Xie C, Yan L, Gong W, Zhu Z, Tan S, Chen D, et al. Effects of different substrates on lignocellulosic enzyme expression, enzyme activity, substrate utilization and biological efficiency of Pleurotus eryngii. Cell Physiol Biochem. 2016;39(4):1479\u201394.","journal-title":"Cell Physiol Biochem"},{"key":"16376_CR25","doi-asserted-by":"crossref","unstructured":"Tang H, Han Z, Zhu W, Lin X, Chen J, Li J, et al. Metformin suppressed epithelial-mesenchymal transition, cisplatin resistance and metastatic potential of ovarian cancer via inhibiting TGF-\u03b21\/Smads. Transl Cancer Res. 2026;15(4):303.","DOI":"10.21037\/tcr-2025-1-2599"},{"issue":"3","key":"16376_CR26","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1159\/000447818","volume":"39","author":"C Li","year":"2016","unstructured":"Li C, Ding H, Tian J, Wu L, Wang Y, Xing Y, et al. Forkhead box protein C2 promotes epithelial-mesenchymal transition, migration and invasion in cisplatin-resistant human ovarian cancer cell line (SKOV3\/CDDP). Cell Physiol Biochem. 2016;39(3):1098\u2013110.","journal-title":"Cell Physiol Biochem"},{"issue":"7","key":"16376_CR27","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1158\/1535-7163.MCT-08-0188","volume":"7","author":"JM Kwok","year":"2008","unstructured":"Kwok JM, Myatt SS, Marson CM, Coombes RC, Constantinidou D, Lam EW. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Mol Cancer Ther. 2008;7(7):2022\u201332.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"16376_CR28","first-page":"953","volume":"42","author":"M Kongsema","year":"2019","unstructured":"Kongsema M, Wongkhieo S, Khongkow M, Lam EW-F, Boonnoy P, Vongsangnak W, et al. Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells. Oncol Rep. 2019;42(3):953\u201362.","journal-title":"Oncol Rep"},{"issue":"5","key":"16376_CR29","doi-asserted-by":"publisher","first-page":"tfaf144","DOI":"10.1093\/toxres\/tfaf144","volume":"14","author":"F Motafeghi","year":"2025","unstructured":"Motafeghi F, Ghassemi Barghi E, Gholami Gharab J, Ghassemi Barghi N, Ramezani Tehrani F. Citrinin and cisplatin synergistically induce apoptosis in SKOV3 ovarian cancer cells via redox imbalance and mitochondrial dysfunction. Toxicol Res. 2025;14(5):tfaf144.","journal-title":"Toxicol Res"},{"issue":"6","key":"16376_CR30","doi-asserted-by":"publisher","first-page":"e23334","DOI":"10.1002\/jbt.23334","volume":"37","author":"H Ahadi","year":"2023","unstructured":"Ahadi H, Shokrzadeh M, Hosseini-khah Z, Ghassemi Barghi N, Ghasemian M, Emami S. Conversion of antibacterial quinolone drug levofloxacin to potent cytotoxic agents. J Biochem Mol Toxicol. 2023;37(6):e23334.","journal-title":"J Biochem Mol Toxicol"},{"issue":"5","key":"16376_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3390\/ph16050755","volume":"16","author":"P Hankittichai","year":"2023","unstructured":"Hankittichai P, Thaklaewphan P, Wikan N, Ruttanapattanakul J, Potikanond S, Smith DR, et al. Resveratrol enhances cytotoxic effects of cisplatin by inducing cell cycle arrest and apoptosis in ovarian adenocarcinoma SKOV-3 cells through activating the p38 MAPK and suppressing AKT. Pharmaceuticals. 2023;16(5):755.","journal-title":"Pharmaceuticals"},{"issue":"4","key":"16376_CR32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/toxres\/tfad060","volume":"12","author":"F Motafeghi","year":"2023","unstructured":"Motafeghi F, Shahsavari R, Mortazavi P, Babaei A, Samadi Mojaveri P, Khojasteh OA, et al. Metformin and Aspirin: Anticancer effects on A549 and PC3 cancer cells and the mechanisms of action. Toxicol Res. 2023;12(4):702\u20138.","journal-title":"Toxicol Res"},{"issue":"3","key":"16376_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/jat.1284","volume":"28","author":"N Martins","year":"2008","unstructured":"Martins N, Santos NAGd, Curti C. Bianchi MdLP, Santos ACd. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J Appl Toxicology: Int J. 2008;28(3):337\u201344.","journal-title":"J Appl Toxicology: Int J"},{"issue":"13","key":"16376_CR34","first-page":"3077","volume":"59","author":"KM Henkels","year":"1999","unstructured":"Henkels KM, Turchi JJ. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and-independent pathways in cisplatin-resistant and-sensitive human ovarian cancer cell lines. Cancer Res. 1999;59(13):3077\u201383.","journal-title":"Cancer Res"},{"issue":"2","key":"16376_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/aivt.2024.0026","volume":"11","author":"N Ghassemi Barghi","year":"2025","unstructured":"Ghassemi Barghi N, Fazeli R, Fakhri MS. Discovering the Hepatoprotective Properties of ARA290 in Acetaminophen-Induced Liver Toxicity. Appl Vitro Toxicol. 2025;11(2):21\u201332.","journal-title":"Appl Vitro Toxicol"},{"key":"16376_CR36","doi-asserted-by":"crossref","unstructured":"Ghassemi Barghi E, Motafeghi F, Gholami Gharab J, Ghassemi Barghi N. Advancing comet assay sensitivity and specificity in genotoxicity research: leveraging artificial intelligence and machine learning for in vitro toxicology. Appl In Vitro Toxicol. 2025;11(4):62\u201372.","DOI":"10.1177\/23321539251386950"},{"issue":"1","key":"16376_CR37","doi-asserted-by":"publisher","first-page":"tfaf023","DOI":"10.1093\/toxres\/tfaf023","volume":"14","author":"F Motafeghi","year":"2025","unstructured":"Motafeghi F, Fakhri BMS, Ghassemi Barghi N. Mechanisms of ARA290 in counteracting cadmium-triggered neurotoxicity in PC12 cells. Toxicol Res. 2025;14(1):tfaf023.","journal-title":"Toxicol Res"},{"key":"16376_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1590\/s0004-2803.201900000-31","volume":"56","author":"M Shokrzadeh","year":"2019","unstructured":"Shokrzadeh M, Mohammadpour A, Modanloo M, Hassani M, Barghi NG, Niroomand P. Cytotoxic effects of aripiprazole on MKN45 and NIH3T3 cell lines and genotoxic effects on human peripheral blood lymphocytes. Arq Gastroenterol. 2019;56:155\u20139.","journal-title":"Arq Gastroenterol"},{"issue":"4","key":"16376_CR39","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1590\/s0004-2803.201900000-71","volume":"56","author":"M Hassani","year":"2019","unstructured":"Hassani M, Ghassemi-Barghi N, Modanloo M, Mohammadpour A, Shokrzadeh M. Cytotoxic effects of duloxetine on MKN45 and NIH3T3 cell lines and genotoxic effects on human peripheral blood lymphocytes. Arq Gastroenterol. 2019;56(4):372\u20136.","journal-title":"Arq Gastroenterol"},{"issue":"1","key":"16376_CR40","first-page":"28","volume":"10","author":"F Motafeghi","year":"2025","unstructured":"Motafeghi F, Ghassemi Barghi E, Gholami Gharab J, Ghassemi Barghi N. Copper Nanoparticles as a Chemosensitizer: Enhancing Bleomycin Cytotoxicity Against MCF-7 Breast Cancer Cells. Nanomed Res J. 2025;10(1):28\u201338.","journal-title":"Nanomed Res J"},{"issue":"3","key":"16376_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/aivt.2023.0005","volume":"9","author":"F Motafeghi","year":"2023","unstructured":"Motafeghi F, Mortazavi P, Shahsavari R, Shaker M, Mohammadi-Berenjestanaki H, Shokrzadeh M. Kombucha mushroom extract: anticancer, antioxidant, and antimicrobial properties. Appl Vitro Toxicol. 2023;9(3):90\u2013103.","journal-title":"Appl Vitro Toxicol"},{"issue":"4","key":"16376_CR42","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/aivt.2023.0008","volume":"9","author":"F Motafeghi","year":"2023","unstructured":"Motafeghi F, Mortazavi P, Zabihi J, Soroori A, Samadi Mojaveri P, Shokrzadeh M. Protective effect of resveratrol on cytotoxicity, genotoxicity, and oxidative stress caused by cyclophosphamide and methotrexate in bone marrow stem cell line and blood lymphocytes of the rat. Appl Vitro Toxicol. 2023;9(4):129\u201336.","journal-title":"Appl Vitro Toxicol"},{"issue":"4","key":"16376_CR43","first-page":"402","volume":"9","author":"E Ghassemi Barghi","year":"2024","unstructured":"Ghassemi Barghi E, Gholami Gharab J, Ghassemi Barghi N. Synergistic Anticancer Effects of Aluminum Oxide Nanoparticle (Al2O3NPs) Combined with Doxorubicin in Inhibiting SK-OV-3 Ovarian Cancer Cell Proliferation. Nanomed Res J. 2024;9(4):402\u201310.","journal-title":"Nanomed Res J"},{"issue":"1","key":"16376_CR44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/aivt.2022.0007","volume":"9","author":"F Motafeghi","year":"2023","unstructured":"Motafeghi F, Khayambashi B, Mortazavi P, Eghbali M, Salmanmahiny A, Shahsavari R, et al. Synergistic Effect of Selenium\/Zinc with Sulfasalazine on the Human Colorectal Cancer Cell Line (HT-29). Appl Vitro Toxicol. 2023;9(1):3\u201312.","journal-title":"Appl Vitro Toxicol"},{"issue":"1","key":"16376_CR45","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s10753-022-01737-7","volume":"46","author":"N Ghassemi-Barghi","year":"2023","unstructured":"Ghassemi-Barghi N, Ehsanfar Z, Mohammadrezakhani O, Ashari S, Ghiabi S, Bayrami Z. Mechanistic approach for protective effect of ARA290, a specific ligand for the erythropoietin\/CD131 heteroreceptor, against cisplatin-induced nephrotoxicity, the involvement of apoptosis and inflammation pathways. Inflammation. 2023;46(1):342\u201358.","journal-title":"Inflammation"},{"issue":"1","key":"16376_CR46","first-page":"57","volume":"26","author":"F Motafeghi","year":"2023","unstructured":"Motafeghi F, Gerami M, Mortazavi P, Khayambashi B, Ghassemi-Barghi N, Shokrzadeh M. Green synthesis of silver nanoparticles, graphene, and silver-graphene nanocomposite using Melissa officinalis ethanolic extract: Anticancer effect on MCF-7 cell line. Iran J Basic Med Sci. 2023;26(1):57.","journal-title":"Iran J Basic Med Sci"},{"issue":"8","key":"16376_CR47","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s00210-021-02119-w","volume":"394","author":"M Shokrzadeh","year":"2021","unstructured":"Shokrzadeh M, Bagheri A, Ghassemi-Barghi N, Rahmanian N, Eskandani M. Doxorubicin and doxorubicin-loaded nanoliposome induce senescence by enhancing oxidative stress, hepatotoxicity, and in vivo genotoxicity in male Wistar rats. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(8):1803\u201313.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4\u20136","key":"16376_CR48","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1159\/000218191","volume":"23","author":"M Montiel","year":"2009","unstructured":"Montiel M, Urso L, De la Blanca EP, Marsigliante S, Jimenez E. Cisplatin reduces endothelial cell migration via regulation of type 2-matrix metalloproteinase activity. Cell Physiol Biochem. 2009;23(4\u20136):441\u20138.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"16376_CR49","first-page":"79","volume":"7","author":"F Shaki","year":"2021","unstructured":"Shaki F, Teymoori M, Motafeghi FS, Hemmati N, Arab-Nozari M. L-arginine ameliorated mitochondrial oxidative damage induced by sub-chronic exposure to cadmium in mice kidney. Pharm Biomedical Res. 2021;7(2):79\u201386.","journal-title":"Pharm Biomedical Res"},{"issue":"1","key":"16376_CR50","first-page":"4048390","volume":"2016","author":"G-S Oh","year":"2016","unstructured":"Oh G-S, Kim H-J, Shen A, Lee S-B, Yang S-H, Shim H, et al. New therapeutic concept of NAD redox balance for cisplatin nephrotoxicity. Biomed Res Int. 2016;2016(1):4048390.","journal-title":"Biomed Res Int"},{"key":"16376_CR51","doi-asserted-by":"publisher","first-page":"104864","DOI":"10.1016\/j.tiv.2020.104864","volume":"66","author":"M Shokrzadeh","year":"2020","unstructured":"Shokrzadeh M, Etebari M, Ghassemi-Barghi N. An engineered non-erythropoietic erythropoietin-derived peptide, ARA290, attenuates doxorubicin induced genotoxicity and oxidative stress. Toxicol In Vitro. 2020;66:104864.","journal-title":"Toxicol In Vitro"},{"issue":"6","key":"16376_CR52","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1007\/s12640-022-00603-6","volume":"40","author":"F Motafeghi","year":"2022","unstructured":"Motafeghi F, Bagheri A, Seyedabadi M, Shaki F, Shokrzadeh M. Antidepressant-Like effects of edaravone and minocycline: Investigation of oxidative stress, neuroinflammation, neurotrophic, and apoptotic pathways. Neurotox Res. 2022;40(6):1838\u201358.","journal-title":"Neurotox Res"},{"issue":"4","key":"16376_CR53","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1590\/s0004-2803.201900000-69","volume":"56","author":"M Shokrzadeh","year":"2019","unstructured":"Shokrzadeh M, Mohammadpour A, Ghassemi-Barghi N, Hoseini V, Abediankenari S, Tabari YS. Metallothionein-2A (rs1610216&rs28366003) gene polymorphisms and the risk of stomach adenocarcinoma. Arq Gastroenterol. 2019;56(4):367\u201371.","journal-title":"Arq Gastroenterol"},{"key":"16376_CR54","doi-asserted-by":"publisher","first-page":"117693512110562","DOI":"10.1177\/11769351211056295","volume":"20","author":"R Ebrahimi","year":"2021","unstructured":"Ebrahimi R, Shokrzadeh M, Ghassemi Barghi N. Effects of melatonin on the Bisphenol-A-induced cytotoxicity and genetic toxicity in colon cancer cell lines, normal gingival cell lines, and bone marrow stem cell lines. Cancer Inform. 2021;20:11769351211056295.","journal-title":"Cancer Inform"},{"key":"16376_CR55","unstructured":"Chen YC, Li H, Wang J. Mechanisms of metformin inhibiting cancer invasion and migration. Am J Transl Res. 2020;12(9):4885\u2013901. PMID: 33042396; PMCID: PMC7540116."},{"issue":"9","key":"16376_CR56","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nchem.1114","volume":"3","author":"NS Hegde","year":"2011","unstructured":"Hegde NS, Sanders DA, Rodriguez R, Balasubramanian S. The transcription factor FOXM1 is a cellular target of the natural product thiostrepton. Nat Chem. 2011;3(9):725\u201331.","journal-title":"Nat Chem"},{"issue":"5","key":"16376_CR57","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.bcp.2012.10.013","volume":"85","author":"M Halasi","year":"2013","unstructured":"Halasi M, Gartel AL. Targeting FOXM1 in cancer. Biochem Pharmacol. 2013;85(5):644\u201352.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"16376_CR58","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 2018;25(3):486\u2013541.","journal-title":"Cell Death Differ"},{"issue":"1","key":"16376_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cdd.2008.150","volume":"16","author":"G Kroemer","year":"2009","unstructured":"Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke E, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell death Differ. 2009;16(1):3\u201311.","journal-title":"Cell death Differ"},{"issue":"11","key":"16376_CR60","doi-asserted-by":"publisher","first-page":"e81162","DOI":"10.1371\/journal.pone.0081162","volume":"8","author":"R Marullo","year":"2013","unstructured":"Marullo R, Werner E, Degtyareva N, Moore B, Altavilla G, Ramalingam SS, et al. Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS ONE. 2013;8(11):e81162.","journal-title":"PLoS ONE"},{"issue":"22","key":"16376_CR61","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1016\/j.febslet.2010.10.046","volume":"584","author":"MT Silva","year":"2010","unstructured":"Silva MT. Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett. 2010;584(22):4491\u20139.","journal-title":"FEBS Lett"},{"issue":"3","key":"16376_CR62","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ymeth.2007.12.001","volume":"44","author":"DV Krysko","year":"2008","unstructured":"Krysko DV, Vanden Berghe T, D\u2019Herde K, Vandenabeele P. Apoptosis and necrosis: detection, discrimination and phagocytosis. Methods. 2008;44(3):205\u201321.","journal-title":"Methods"},{"issue":"12","key":"16376_CR63","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1158\/1535-7163.MCT-11-0536","volume":"10","author":"M Wang","year":"2011","unstructured":"Wang M, Gartel AL. Micelle-encapsulated thiostrepton as an effective nanomedicine for inhibiting tumor growth and for suppressing FOXM1 in human xenografts. Mol Cancer Ther. 2011;10(12):2287\u201397.","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"16376_CR64","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41419-022-05082-3","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Gong M, Zhang W, Mo J, Zhang S, Zhu Z, et al. Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3\/GPX4 signalling. Cell Death Dis. 2022;13(7):630.","journal-title":"Cell Death Dis"},{"issue":"10","key":"16376_CR65","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3390\/jcm8101658","volume":"8","author":"M Teeuwssen","year":"2019","unstructured":"Teeuwssen M, Fodde R. Wnt signaling in ovarian cancer stemness, EMT, and therapy resistance. J Clin Med. 2019;8(10):1658.","journal-title":"J Clin Med"},{"issue":"3","key":"16376_CR66","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.ygyno.2013.09.034","volume":"131","author":"RC Arend","year":"2013","unstructured":"Arend RC, Londo\u00f1o-Joshi AI, Straughn JM Jr, Buchsbaum DJ. The Wnt\/\u03b2-catenin pathway in ovarian cancer: a review. Gynecol Oncol. 2013;131(3):772\u20139.","journal-title":"Gynecol Oncol"},{"issue":"27","key":"16376_CR67","doi-asserted-by":"publisher","first-page":"23720","DOI":"10.18632\/oncotarget.4690","volume":"6","author":"AB Nagaraj","year":"2015","unstructured":"Nagaraj AB, Joseph P, Kovalenko O, Singh S, Armstrong A, Redline R, et al. Critical role of Wnt\/\u03b2-catenin signaling in driving epithelial ovarian cancer platinum resistance. Oncotarget. 2015;6(27):23720\u201334.","journal-title":"Oncotarget"},{"key":"16376_CR68","first-page":"2022","volume":"12","author":"W Wang","year":"2022","unstructured":"Wang W, Cho U, Yoo A, Jung C-L, Kim B, Kim H, et al. Wnt\/\u03b2-Catenin Inhibition by CWP232291 as a Novel Therapeutic Strategy in Ovarian Cancer. Front Oncol. 2022;12:2022.","journal-title":"Front Oncol"},{"issue":"4","key":"16376_CR69","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","volume":"22","author":"E-h Jho","year":"2002","unstructured":"Jho E-h, Zhang T, Domon C, Joo C-K, Freund J-N, Costantini F. Wnt\/\u03b2-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002;22(4):1172\u201383.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"16376_CR70","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1128\/MCB.22.4.1184-1193.2002","volume":"22","author":"B Lustig","year":"2002","unstructured":"Lustig B, Jerchow B, Sachs M, Weiler S, Pietsch T, Karsten U, et al. Negative feedback loop of Wnt signaling through upregulation of conductin\/axin2 in colorectal and liver tumors. Mol Cell Biol. 2002;22(4):1184\u201393.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"16376_CR71","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccr.2011.08.016","volume":"20","author":"N Zhang","year":"2011","unstructured":"Zhang N, Wei P, Gong A, Chiu W-T, Lee H-T, Colman H, et al. FoxM1 promotes \u03b2-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell. 2011;20(4):427\u201342.","journal-title":"Cancer Cell"},{"issue":"11","key":"16376_CR72","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.bbagrm.2014.09.016","volume":"1839","author":"S Zona","year":"2014","unstructured":"Zona S, Bella L, Burton MJ, de Moraes GN, Lam EW-F. FOXM1: an emerging master regulator of DNA damage response and genotoxic agent resistance. Biochim et Biophys Acta (BBA)-Gene Regul Mech. 2014;1839(11):1316\u201322.","journal-title":"Biochim et Biophys Acta (BBA)-Gene Regul Mech"},{"issue":"14","key":"16376_CR73","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.3390\/ijms22147379","volume":"22","author":"M Wangpaichitr","year":"2021","unstructured":"Wangpaichitr M, Theodoropoulos G, Nguyen DJ, Wu C, Spector SA, Feun LG, et al. Cisplatin resistance and redox-metabolic vulnerability: a second alteration. Int J Mol Sci. 2021;22(14):7379.","journal-title":"Int J Mol Sci"},{"issue":"19","key":"16376_CR74","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1038\/emboj.2009.239","volume":"28","author":"HJ Park","year":"2009","unstructured":"Park HJ, Carr JR, Wang Z, Nogueira V, Hay N, Tyner AL, et al. FoxM1, a critical regulator of oxidative stress during oncogenesis. EMBO J. 2009;28(19):2908.","journal-title":"EMBO J"},{"issue":"1","key":"16376_CR75","doi-asserted-by":"publisher","first-page":"15140","DOI":"10.1038\/s41598-017-15474-7","volume":"7","author":"I Azimi","year":"2017","unstructured":"Azimi I, Petersen RM, Thompson EW, Roberts-Thomson SJ, Monteith GR. Hypoxia-induced reactive oxygen species mediate N-cadherin and SERPINE1 expression, EGFR signalling and motility in MDA-MB-468 breast cancer cells. Sci Rep. 2017;7(1):15140.","journal-title":"Sci Rep"},{"key":"16376_CR76","doi-asserted-by":"crossref","unstructured":"Thinnes WE, Duke JD, Katsis J, Shojaee S. Indwelling pleural catheters for the treatment of malignant pleural effusions; where are we now?. Expert Rev Respir Med. 2026;20(4):359\u201367. https:\/\/clinicaltrials.gov\/study\/NCT05278975.","DOI":"10.1080\/17476348.2025.2582248"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16376-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16376-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16376-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:04:10Z","timestamp":1788224650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16376-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16376"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16376-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,20]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1034"}}